224 related articles for article (PubMed ID: 28974115)
21. Proteomics for hematopoietic stem cell transplantation.
Weissinger EM; Basílio-Queirós D; Metzger J; Bieling LM; Ganser A
Expert Rev Proteomics; 2020 Mar; 17(3):201-206. PubMed ID: 32228239
[No Abstract] [Full Text] [Related]
22. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers for acute and chronic graft-versus-host disease in regulatory T cells.
Ukena SN; Geffers R; Buchholz S; Stadler M; Franzke A
Transpl Immunol; 2012 Dec; 27(4):179-83. PubMed ID: 22889700
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of biomarkers associated with acute and chronic graft versus host disease.
Ahmed SS; Wang XN; Norden J; Pearce K; El-Gezawy E; Atarod S; Hromadnikova I; Collin M; Holler E; Dickinson AM
Bone Marrow Transplant; 2015 Dec; 50(12):1563-71. PubMed ID: 26367225
[TBL] [Abstract][Full Text] [Related]
25. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
26. Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation.
Inamoto Y; Martin PJ; Lee SJ; Momin AA; Tabellini L; Onstad LE; Pidala J; Flowers MED; Lawler RL; Katayama H; Hanash S; Hansen JA
Blood Adv; 2020 Jun; 4(11):2409-2417. PubMed ID: 32492155
[TBL] [Abstract][Full Text] [Related]
27. [Significance of ST2 in the Early Diagnosis and Treatment of Graft-Versus-Host Disease--Review].
Lu RQ; Guo R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):307-10. PubMed ID: 26913443
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers.
De Bock M; Beguin Y; Leprince P; Willems E; Baron F; Deroyer C; Seidel L; Cavalier E; de Seny D; Malaise M; Gothot A; Merville MP; Fillet M
Talanta; 2014 Jul; 125():265-75. PubMed ID: 24840443
[TBL] [Abstract][Full Text] [Related]
29. Colonic graft-versus-host disease.
Ross WA; Couriel D
Curr Opin Gastroenterol; 2005 Jan; 21(1):64-9. PubMed ID: 15687887
[TBL] [Abstract][Full Text] [Related]
30. [Biomarkers of graft-versus-host disease following allogeneic hematopoietic cell transplantation].
Nakasone H
Rinsho Ketsueki; 2020; 61(4):379-386. PubMed ID: 32378584
[TBL] [Abstract][Full Text] [Related]
31. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Qayed M; Kapoor U; Gillespie S; Westbrook A; Aguayo-Hiraldo P; Ayuk FA; Aziz M; Baez J; Choe H; DeFilipp Z; Etra A; Grupp SA; Hexner E; Holler E; Hogan WJ; Kowalyk S; Merli P; Morales G; Nakamura R; Pulsipher MA; Schechter T; Shah J; Spyrou N; Srinagesh HK; Wölfl M; Yanik G; Young R; Kitko CL; Ferrara JLM; Levine JE
Transplant Cell Ther; 2024 Jun; 30(6):603.e1-603.e11. PubMed ID: 38548227
[TBL] [Abstract][Full Text] [Related]
32. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
[TBL] [Abstract][Full Text] [Related]
33. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
34. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
Funke VA; Moreira MC; Vigorito AC
Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():44-50. PubMed ID: 27982319
[TBL] [Abstract][Full Text] [Related]
35. A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft-versus-host disease.
Pratta M; Paczesny S; Socie G; Barkey N; Liu H; Owens S; Arbushites MC; Schroeder MA; Howell MD
Br J Haematol; 2022 Aug; 198(4):729-739. PubMed ID: 35689489
[TBL] [Abstract][Full Text] [Related]
36. Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Schultz KR; Miklos DB; Fowler D; Cooke K; Shizuru J; Zorn E; Holler E; Ferrara J; Shulman H; Lee SJ; Martin P; Filipovich AH; Flowers ME; Weisdorf D; Couriel D; Lachenbruch PA; Mittleman B; Vogelsang GB; Pavletic SZ
Biol Blood Marrow Transplant; 2006 Feb; 12(2):126-37. PubMed ID: 16443511
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
38. Extracellular vesicles as potential biomarkers of acute graft-vs-host disease.
Lia G; Brunello L; Bruno S; Carpanetto A; Omedè P; Festuccia M; Tosti L; Maffini E; Giaccone L; Arpinati M; Ciccone G; Boccadoro M; Evangelista A; Camussi G; Bruno B
Leukemia; 2018 Mar; 32(3):765-773. PubMed ID: 28852198
[TBL] [Abstract][Full Text] [Related]
39. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease.
Bidgoli A; DePriest BP; Saatloo MV; Jiang H; Fu D; Paczesny S
Transplant Cell Ther; 2022 Oct; 28(10):657-666. PubMed ID: 35830932
[TBL] [Abstract][Full Text] [Related]
40. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
